6-bromo-1-tetrahydropyran-4-ylindole | 321745-21-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 6-bromo-1-tetrahydropyran-4-ylindole
• 英文别名: 6-Bromo-1-(tetrahydropyran-4-yl)-indole；6-bromo-1-(oxan-4-yl)indole
• CAS: 321745-21-5
• 化学式: C₁₃H₁₄BrNO
• 分子量: 280.164
• InChiKey: HSXPZXWZIFGDEC-UHFFFAOYSA-N

物化性质

• 沸点：
  411.4±35.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  14.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-bromo-2-[(tetrahydropyran4-yl)amino]-phenylacetaldehyde dimethyl acetal 在 盐酸 作用下， 以 甲醇 为溶剂， 反应 2.0h， 以96%的产率得到6-bromo-1-tetrahydropyran-4-ylindole
  参考文献：
  名称：

  Heterocyclic compounds for the treatment of migraine

  摘要：

  本文描述了在治疗偏头痛中有用的化合物，其具有以下一般公式：其中：W是一个CH基团或一个N原子；Z是N或C—R4；B和D分别从CH和N中选择，但至少其中一个是CH，并进一步规定其中一个可以表示N，只有当W和Z都不是N时；A是公式II、III或IV的一个基团，使得基团A至少含有1个N原子；NR7要么是—NH—要么是—N═; 是一个单键或双键；X是一个N原子、一个CH基团或一个C(OH)基团，当 是一个单键时；或者，当 是一个双键时，是一个C原子；Y是一个NH、N-烷基、N-苄基或CH2基团；U和V分别代表一个N原子或一个CH基团，但两者不能都是N；a和b分别独立地为0或1；c是一个从0到3的整数；d是一个从1到3的整数；e是一个从1到2的整数；f是一个从0到3的整数；g是一个从3到6的整数，h是一个从2到3的整数；使得c和d的总和至少为2，e和f的总和至少为2；以及它们的盐和溶剂化合物。

  公开号：

  US06716837B1

文献信息

• [EN] REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS<br/>[FR] AGONISTES REV-ERB POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES À MÉDIATION PAR TH17
  申请人：SCRIPPS RESEARCH INST

  公开号：WO2021263278A1

  公开（公告）日：2021-12-30

  The present disclosure provides compounds of Formula IA and Formula IB and their pharmaceutical compositions as selective agonists of REV-ERB-α: where R1, R2, R3, R4, R5, RX1, RX2, nA, nB, X, Y, and Z are described herein. The compounds are useful in various methods and uses, such as in the treatment of diseases including hyperglycemia, dyslipidemia, atherosclerosis, and autoimmune and inflammatory disorders or diseases, and as cancer therapeutics, such as for the treatment of glioblastoma, hepatocellular carcinoma, and colorectal cancer, and for immune-oncology purposes.

  本公开提供了Formula IA和Formula IB的化合物及其作为REV-ERB-α选择性激动剂的药物组合物：其中R1、R2、R3、R4、R5、RX1、RX2、nA、nB、X、Y和Z如本文所述。这些化合物在各种方法和用途中非常有用，例如用于治疗包括高血糖、血脂异常、动脉粥样硬化、自身免疫和炎症性疾病等疾病，以及作为癌症治疗药物，如用于治疗胶质母细胞瘤、肝细胞癌和结直肠癌，以及用于免疫肿瘤学目的。
• INDOLES AND INDAZOLES FOR THE TREATMENT OF MIGRAINE
  申请人：NPS Allelix Corp.

  公开号：EP1196380A2

  公开（公告）日：2002-04-17
• US6716837B1
  申请人：——

  公开号：US6716837B1

  公开（公告）日：2004-04-06
• [EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MIGRAINE<br/>[FR] COMPOSES HETEROCYCLIQUES DESTINES AU TRAITEMENT DE LA MIGRAINE
  申请人：NPS ALLELIX CORP

  公开号：WO2001005758A2

  公开（公告）日：2001-01-25

  Described herein are compounds useful in the treatment of migraine, which have general formulae (I), (II), (III) and (IV), wherein : W is a CH group or an N atom ;Z is N or C-R4; B and D are selected independently from CH and N, with the proviso that at least one of B and D is CH and with the further proviso that one of B and D can represent N only when W and Z are both other than N; A is a group of Formula (II), (III) or (IV), such that group A contains at least 1 N atom ; NR7 is either -NH- or -N=--- is a single or double bond ; X is an N atom, a CH group or a C(OH) group when --- is a single bond; or, when --- is a double bond, a C atom; Y is an NH, N-alkyl, N-benzyl or CH2 group; U and V each represent an N atom or a CH group, with the proviso that both cannot be N; a and b are, independently, 0 or 1; c is an integer from 0 to 3; d is an integer from 1 to 3; e is an integer from 1 to 2; f is an integer from 0 to 3; g is an integer from 3 to 6 and h is an integer from 2 to 3; such that the sum of c and d is at least 2 and the sum of e and f is at least 2; R1 is selected from the group consisting of H, alkyl, alkyloxy, alkanoyl, aminoalkylenyl, alkylaminoalkylenyl, a hydroxyalkylenyl group, an alkyloxyalkylenyl group, a cycloalkyl group, a cycloalkylalkylenyl group, a heterocycloalkyl group, a heterocycloalkylalkylenyl group, an aryl group, a heterocycloaryl group, an amido group, a thioamido group, an arylcarbonyl group and an arylsulfonyl group; R2 and R3 are independently selected from the group consisting of H, alkyl, cycloalkyl, alkenyl and optionally-substituted benzyl; or R2 and R3, together with the nitrogen atom to which they are attached, may form a mono- or bi-cyclic group containing up to 10 carbon atoms and which, in addition, may contain a second heteroatom selected from the group consisting of N, S and O, and which may contain one or more substituents selected from the group consisting of alkyl, hydroxy, hydroxymethyl, alkyloxymethyl, amino and substituted amino; R4 is selected from the group consisting of H, alkyl and cycloalkyl; CR5 represents a group selected from -CH2-, CH(OH)-, -C(O)-, -CH(alkyl)- and -CH(alkyloxy)-; R6 is selected from the group consisting of H, alkyl, aryl, halogen, hydroxy, alkyloxy, amino, monoalkylamino and di-substituted alkylamino; and salts and solvates thereof.
• Heterocyclic compounds for the treatment of migraine
  申请人：NPS Allelix Biopharmaceuticals, Inc.

  公开号：US06716837B1

  公开（公告）日：2004-04-06

  Described herein are compounds useful in the treatment of migraine, which have the general formula: wherein: W is a CH group or a N atom; Z is N or C—R4; B and D are selected independently from CH and N, with the proviso that at least one of B and D is CH and with the further proviso that one of B and D can represent N only when W and Z are both other than N; A is a group of Formula II, III or IV, such that group A contains at least 1 N atom; NR7 is either —NH— or —N═; is a single or double bond; X is a N atom, a CH group or a C(OH) group when is a single bond; or, when is a double bond, a C atom; Y is an NH, N-alkyl, N-benzyl or CH2 group; U and V each represent a N atom or a CH group, with the proviso that both cannot be N; a and b are, independently, 0 or 1; c is an integer from 0 to 3; d is an integer from 1 to 3; e is an integer from 1 to 2; f is an integer from 0 to 3; g is an integer from 3 to 6 and h is an integer from 2 to 3; such that the sum of c and d is at least 2 and the sum of e and f is at least 2; and salts and solvates thereof.

  本文描述了在治疗偏头痛中有用的化合物，其具有以下一般公式：其中：W是一个CH基团或一个N原子；Z是N或C—R4；B和D分别从CH和N中选择，但至少其中一个是CH，并进一步规定其中一个可以表示N，只有当W和Z都不是N时；A是公式II、III或IV的一个基团，使得基团A至少含有1个N原子；NR7要么是—NH—要么是—N═; 是一个单键或双键；X是一个N原子、一个CH基团或一个C(OH)基团，当 是一个单键时；或者，当 是一个双键时，是一个C原子；Y是一个NH、N-烷基、N-苄基或CH2基团；U和V分别代表一个N原子或一个CH基团，但两者不能都是N；a和b分别独立地为0或1；c是一个从0到3的整数；d是一个从1到3的整数；e是一个从1到2的整数；f是一个从0到3的整数；g是一个从3到6的整数，h是一个从2到3的整数；使得c和d的总和至少为2，e和f的总和至少为2；以及它们的盐和溶剂化合物。